Category Archives: Health

Latest From Health

BIO Releases Largest Study Ever on Clinical Development Success Rates

new-bio-logo

On Wednesday, BIO released the largest ever study of clinical development success rates. The study, conducted in partnership with Amplion and Biomedtracker, recorded and analyzed 9,985 clinical and regulatory phase transitions, across 1,103 companies. Using clinical trial data from the past decade, “Clinical Development Success Rates 2006-2015” compares groups of diseases, drug modalities and other attributes to generate the most comprehensive analysis, to date, of biopharmaceutical R&D success. “This study provides a wealth of information about drug development success rates Read More >

Inside BIO Industry Analysis  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , ,

A Closer Look at AHIP’s Claims

new-bio-logo

This morning, in a letter to the editor of the New York Times, Marilyn Tavenner, President and CEO of America’s Health Insurance Plans (AHIP), attempted to lay the blame for higher healthcare costs and insurance premiums at the feet of America’s cutting-edge biopharma companies. AHIP has been peddling these falsehoods and misinformation for years.  Tavenner’s (and her organization’s) claims are—at best—uninformed. At worst, they are outright distortions deployed to hide the facts from patients who Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

Morning Consult: Medicare’s Deadly Cancer Care Gamble

new-bio-logo

Today in Morning Consult, cancer survivor and health economist Jennifer Hinkel writes about the threat posed to cancer patients by CMS’s proposed Medicare Part B drug payment model: Who will bear the most significant burden? It will be the poorest, oldest, and least educated patients who will struggle to understand whether they and their doctors have been assigned to the “experimental arm” of this reimbursement research trial. These Medicare beneficiaries will be the unwitting subjects Read More >

Health  |  Leave a comment  |  Email This Post
Tags: ,

Harvard Law Advocates for Patient Access to Hepatitis C Cure

new-bio-logo

There is hope for the 3.5 million people living with Hepatitis C virus (HCV) in the United States. Therapies approved in recent years can eliminate the virus in 96 to 99 percent of patients, according to Harvard Law’s article “The Price of Life.” So why is there is still such a high number of people infected with this disease? Ask the Washington State Health Care Authority (HCA) whom Harvard Law’s Center for Health Law and Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , ,

Report Finds Increasing Number of 340B Hospitals Provide Minimal Charity Care

A new report released yesterday by the Alliance for Integrity and Reform of 340B (AIR340B), of which BIO is a member, found a dramatic decline in charity care provided by 340B hospitals in 2014, which was the first year of coverage expansion under the Affordable Care Act. The report found that over a third (37 percent) provided charity care representing less than 1 percent of total patient costs – far higher than the 24 percent Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , ,